Aquestive Therapeutics In...
3.04
-0.07 (-2.25%)
At close: Jan 14, 2025, 3:59 PM
3.06
0.49%
After-hours Jan 14, 2025, 04:07 PM EST

Aquestive Therapeutics Inc. Revenue Breakdown

Quarter Sep 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018
Co-Development and Research Fees Revenue 492.00K 403.00K 335.00K 490.00K 124.00K 453.00K 254.00K 395.00K 241.00K 403.00K 218.00K 523.00K 456.00K 2.36M 394.00K 328.00K 12.93M 426.00K 1.18M 1.36M 424.00K 4.62M 1.21M 907.00K 712.00K
Co-Development and Research Fees Revenue Growth +22.08% +20.30% -31.63% +295.16% -72.63% +78.35% -35.70% +63.90% -40.20% +84.86% -58.32% +14.69% -80.69% +499.24% +20.12% -97.46% +2934.74% -63.90% -12.98% +219.81% -90.83% +280.72% +33.85% +27.39% n/a
License and Royalty Revenue Revenue 2.16M 1.13M 1.87M 1.10M 1.48M 919.00K 917.00K 376.00K 552.00K 506.00K 380.00K 328.00K 10.66M 6.51M 373.00K 5.90M 7.26M 6.92M 557.00K 9.15M 8.91M 6.67M 7.31M 3.35M 8.68M
License and Royalty Revenue Revenue Growth +90.99% -39.56% +69.81% -25.52% +61.15% +0.22% +143.88% -31.88% +9.09% +33.16% +15.85% -96.92% +63.80% +1645.58% -93.68% -18.68% +4.96% +1141.65% -93.92% +2.69% +33.68% -8.79% +117.94% -61.37% n/a
Manufacture and Supply Revenue Revenue 10.67M 10.52M 11.00M 11.41M 11.64M 9.76M 8.92M 8.41M 9.87M 9.17M 7.69M 10.45M n/a n/a 4.80M n/a n/a n/a 14.00M n/a n/a n/a 8.07M 9.01M n/a
Manufacture and Supply Revenue Revenue Growth +1.45% -4.36% -3.60% -1.95% +19.20% +9.41% +6.08% -14.82% +7.67% +19.27% -26.40% n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -10.38% n/a n/a
Manufactured Product, Other Revenue 217.00K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Manufactured Product, Other Revenue Growth n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a

Revenue by Geography

Quarter Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019
Non-Us Revenue 13.48M 7.76M 7.97M 4.89M 4.32M
Non-Us Revenue Growth +73.72% -2.67% +62.93% +13.37% n/a
United States Revenue 37.10M 39.92M 42.86M n/a n/a
United States Revenue Growth -7.06% -6.86% n/a n/a n/a

Operating Expense Breakdown

Quarter Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018Mar 31, 2018Dec 31, 2017Sep 30, 2017Jun 30, 2017Mar 31, 2017
Selling, General, and Administrative Revenue 12.13M 11.36M 10.69M 9.55M 7.38M 7.36M 7.46M 11.81M 12.46M 15.59M 13.02M 14.98M 12.13M 13.13M 13.23M 15.58M 11.80M 13.89M 14.61M 16.47M 13.71M 16.25M 17.91M 18.70M 12.35M 33.65M 7.57M 7.57M 6.16M 5.22M 6.13M
Selling, General, and Administrative Revenue Growth +6.78% +6.24% +11.93% +29.32% +0.34% -1.27% -36.89% -5.19% -20.07% +19.71% -13.08% +23.51% -7.65% -0.73% -15.09% +32.02% -15.05% -4.92% -11.30% +20.13% -15.59% -9.28% -4.25% +51.50% -63.31% +344.54% +0.05% +22.79% +17.96% -14.77% n/a
Research and Development Revenue 5.27M 4.16M 5.93M 2.89M 3.20M 3.47M 3.55M 4.28M 3.23M 5.20M 4.77M 4.40M 4.73M 4.26M 3.66M 4.42M 7.26M 3.85M 4.35M 3.06M 5.06M 8.15M 4.30M 5.68M 4.53M 7.99M 4.90M 6.27M 5.68M 4.84M 5.34M
Research and Development Revenue Growth +26.60% -29.84% +105.40% -9.64% -7.98% -2.09% -17.09% +32.36% -37.82% +8.90% +8.48% -6.90% +10.89% +16.48% -17.31% -39.05% +88.72% -11.64% +42.43% -39.62% -37.88% +89.43% -24.28% +25.34% -43.28% +63.11% -21.85% +10.33% +17.51% -9.47% n/a

Create Price Alert on AQST

Your price alert will notify you when the stock price is above 3.04.

Add to Watchlist